NYSEMKT: CATX
Perspective Therapeutics Inc Earnings Dates, Reports, Calls

Perspective Therapeutics earnings were -$63.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CATX earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$15.1M, up 29.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CATX reported annual earnings of -$46.5M, with 539.5% growth.

CATX earnings history

Current Revenue
-$3.7M
Current Earnings
-$63.8M
Current Profit Margin
1,732.3%

CATX Return on Equity

Current Company
-26.2%
Current Industry
11.4%
Current Market
35%
CATX's Return on Equity (-26.2%)... subscribe to Premium to read more.
High Return on Equity Performance

CATX undefined

Current Company
-22.1%
Current Industry
6.6%
CATX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CATX announces earnings.

CATX undefined

Current Company
-15.37%
Current Industry
8.8%
CATX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CATX vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CATX-$53.78M-$63.79MN/A-$1.49
NVRO-$37.46M-$69.31MN/A-$1.88
MYO-$7.64M-$8.38MN/A-$0.23
BWAY$6.68M$1.50MN/A$0.08
ARAY$21.41M-$4.37MN/A-$0.04

Perspective Therapeutics Earnings Reports & History FAQ

What were Perspective Therapeutics's earnings last quarter?

Perspective Therapeutics (NYSEMKT: CATX) reported Q3 2024 earnings per share (EPS) of -$0.21, up 43.24% year over year. Total CATX earnings for the quarter were -$15.12 million. In the same quarter last year, Perspective Therapeutics's earnings per share (EPS) was -$0.37.

If you're new to stock investing, here's how to buy Perspective Therapeutics stock.

Is Perspective Therapeutics profitable or losing money?

As of the last Perspective Therapeutics earnings report, Perspective Therapeutics is currently losing money. Perspective Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$63.79 million, a 154.12% increase year over year.

What was CATX's earnings growth in the past year?

As of Perspective Therapeutics's earnings date in Q1 2025, Perspective Therapeutics's earnings has grown year over year. CATX earnings in the past year totalled -$63.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.